Valuation : Terumo Corporation

Market Cap 3,776B 23.68B 20.33B 19.05B 17.43B 32.8B 2,263B 32.94B 224B 87.95B 1,142B 88.97B 87.03B P/E 2027 *
19.8x
P/E 2028 * 19.7x
Enterprise Value 3,831B 24.03B 20.63B 19.32B 17.68B 33.28B 2,296B 33.42B 227B 89.22B 1,158B 90.26B 88.29B EV / Sales 2027 *
3.05x
EV / Sales 2028 * 2.81x
Free-Float
97.07%
Yield 2027 *
1.45%
Yield 2028 * 1.59%
1 day-0.47%
1 week+3.56%
Current month+10.15%
1 month+13.83%
3 months+9.66%
6 months+25.03%
Current year+12.78%
1 week 2,526.5
Extreme 2526.5
2,645.5
1 month 2,177.5
Extreme 2177.5
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,708
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+3.56%-3.25%+19.21% 23.81B
-2.20%-2.48%-15.20%+7.08% 197B
-2.23%-4.42%-2.40%+9.47% 118B
-2.00%+1.30%+10.88%+78.98% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
-1.09%+0.28%-3.06%-32.81% 51.81B
+0.37%-0.66%+17.30%-11.38% 33.57B
+0.20%+2.18% - - 30.34B
-1.09%-1.90%+41.55%-12.10% 24.63B
-1.60%-1.66%-6.28%+2.90% 23.09B
Average -0.69%+0.78%+7.40%+12.76% 61.74B
Weighted average by Cap. -0.41%+0.07%+0.06%+14.31%

Financials

2027 *2028 *
Net sales 1,256B 7.88B 6.76B 6.33B 5.8B 10.91B 753B 10.95B 74.36B 29.25B 380B 29.59B 28.94B 1,336B 8.38B 7.19B 6.74B 6.17B 11.6B 801B 11.65B 79.1B 31.12B 404B 31.48B 30.79B
Net income 189B 1.18B 1.02B 952M 871M 1.64B 113B 1.65B 11.17B 4.4B 57.06B 4.45B 4.35B 191B 1.2B 1.03B 964M 882M 1.66B 115B 1.67B 11.32B 4.45B 57.79B 4.5B 4.41B
Net Debt 54.63B 343M 294M 276M 252M 475M 32.74B 477M 3.23B 1.27B 16.52B 1.29B 1.26B -16.66B -105M -89.72M -84.05M -76.92M -145M -9.99B -145M -987M -388M -5.04B -393M -384M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
27/08/26 JP¥2,560.00 -0.47% 2,949,800
26/08/26 JP¥2,572.00 -0.94% 3,286,000
25/08/26 JP¥2,596.50 +0.04% 3,106,200
24/08/26 JP¥2,595.50 +1.03% 3,082,000
21/08/26 JP¥2,569.00 -0.29% 4,562,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,560.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+22.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock